Also Known As
Ipamorelin Acetate
Overview
Ipamorelin is a pentapeptide GHRP that stimulates GH release. Known for being highly selective with minimal impact on cortisol and prolactin.
Mechanism of Action
Binds to ghrelin receptors in the pituitary, triggering GH release without significantly affecting other hormones.
Quick Reference
Common Dose 100-300mcg
Frequency 2-3x daily
Half-Life ~2 hours
Storage Refrigerate reconstituted.
Dosing Protocol
Typical Dose 200 mcg
Range 100 - 300 mcg
Maintenance 200 mcg 2-3x daily
Pharmacokinetics
Half-Life 2.0 hrs
Onset 10 min
Peak 30 min
Duration 3.0 hrs
Bioavailability 95%
Primary Route Subcutaneous
Administration
Routes Subcutaneous
Injection Sites Abdomen, Thigh, Deltoid
Needle Gauge 29-31G
Syringe Type Insulin
Timing Before Bed, Fasted, Morning
Reconstitution
Diluent Bacteriostatic Water
Volume 2 mL
Concentration 2500 mcg/mL
Stability 21 days refrigerated
Vial Sizes 5 mg
Special Instructions
Most selective GHRP with minimal hunger/cortisol effects. Best combined with CJC-1295.
Warnings
May affect blood glucose
Not FDA approved
Contraindications
PregnancyBreastfeedingActive Cancer
Drug Interactions
Insulin
Possible Side Effects
Water RetentionTinglingHeadache
Legal & Regulatory
FDA Status Research Only
WADA Status Prohibited in Sport
Prescription Not Required
Pregnancy
Category X - Contraindicated
Molecular Data
Formula C38H49N9O5
Molecular Weight 711.9 g/mol
Amino Acids 5
CAS Number 170851-70-4
PubChem CID 9831659
No sources available yet.
Related Peptides
No community data available yet. Be the first to add this peptide to your inventory!